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To determine whether HIV-1 infection and HIV-1–relat-
ed immunosuppression were risk factors for severe malaria 
in adults with some immunity to malaria, we conducted a 
case–control study in Luanshya, Zambia, during Decem-
ber 2005–March 2007. For each case-patient with severe 
malaria, we selected 2 matched controls (an adult with un-
complicated malaria and an adult without signs of disease). 
HIV-1  infection  was  present  in  93%  of  case-patients,  in 
52% of controls with uncomplicated malaria, and in 45% of 
asymptomatic  controls.  HIV-1  infection  was  a  highly  sig-
ni?  cant risk factor for adults with severe malaria compared 
with controls with uncomplicated malaria (odds ratio [OR] 
12.6, 95% con?  dence interval [CI] 2.0–78.8, p = 0.0005) 
and asymptomatic controls (OR 16.6, 95% CI 2.5–111.5, p 
= 0.0005). Persons with severe malaria were more likely to 
have a CD4 count <350/μL than were asymptomatic con-
trols (OR 23.0, 95% CI 3.35–158.00, p<0.0001).
T
he geographic overlap between HIV-1 infection and 
malaria, particularly in eastern and southern Africa, 
has caused concern since the 1980s. The degree of inter-
action between HIV-1 infection and malaria emerged dur-
ing 1999–2009 and has been extensively reviewed for both 
nonpregnant and pregnant adult women (1,2). The effect of 
HIV-1 on malaria seems to be driven mainly by the incapac-
ity of the immune system to control parasite load, leading 
to a higher prevalence of infection (3), a higher incidence 
of clinical malaria (4,5), and a risk for treatment failure (6)
in immunosuppressed HIV-1 patients.
Reports of HIV-1 infection as a risk factor for hyper-
parasitemia or severe malaria are few and limited. In urban 
Burkina Faso, >30% of adults with severe malaria were 
also infected with HIV-1, whereas HIV-1 prevalence in the 
general adult population was ≈5%–14% (7). In South Af-
rica, in an area of low malaria transmission (<1 case/1000/
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Learning Objectives
Upon completion of this activity, participants will be able to:
Describe the impact of HIV infection on malaria infection • 
Identify different levels of severity of malaria infection • 
Describe the presentation of severe malaria in patients infected with HIV-1 in one region in Zambia • 
Compare the risk for severe malaria in relation to CD4 count in patients infected with HIV-1 • 
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Activity Evaluation
1. Which of the following best explains the large scale 
of the HIV-1–malaria interaction that has emerged in 
the last decade?
A.   Longer survival of patients infected with HIV 
B.   Effects of increased antiretroviral drug use
C.   Poor immune function and higher susceptibility
D.   Poor control of malaria worldwide
2. A 28-year-old Zambian patient presents with a fever 
of 38.5°C, Plasmodium falciparum on thick smear with 
120 parasites per 200 white blood cells, and jaundice. 
Which of the following best describes the likely 
diagnosis?
A.   Uncomplicated malaria
B.   Moderately severe malaria
C.   Severe malaria
D.   HIV and malaria
3. The study noted the importance of fever as an 
indicator of severe malaria in patients infected with 
HIV-1. Which of the following features were most 
commonly encountered in addition to fever?
A.   Impaired consciousness and jaundice
B.  Impaired consciousness and hypoglycemia
C.   Multiple convulsions and jaundice
D.   Hypoglycemia and jaundice
4. Which of the following best describes the 
association between HIV-1 infection and risk for 
severe malaria in the population studied?
A.   HIV-1 infection is a risk factor for uncomplicated and 
severe malaria
B.   Risk for severe malaria is only increased in patients 
with HIV-1 with a CD4 count <250 cells/µL
C.   HIV-1 infection increases the risk for severe malaria
D.   Risk for severe malaria is increased only in patients 
with AIDS
1. The activity supported the learning objectives. 
Strongly Disagree Strongly Agree 
1 5 4 3 2
2. The material was organized clearly for learning to occur.
Strongly Disagree Strongly Agree
5 4 3 2 1
3. The content learned from this activity will impact my practice.
Strongly Disagree Strongly Agree
5 4 3 2 1
4. The activity was presented objectively and free of commercial bias.
Strongly Disagree Strongly Agree
5 4 3 2 1